Mark Dovey

1.2k total citations
13 papers, 874 citations indexed

About

Mark Dovey is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Mark Dovey has authored 13 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Mark Dovey's work include Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (4 papers) and Asthma and respiratory diseases (4 papers). Mark Dovey is often cited by papers focused on Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (4 papers) and Asthma and respiratory diseases (4 papers). Mark Dovey collaborates with scholars based in United States, United Kingdom and Canada. Mark Dovey's co-authors include David A. Waltz, Ronald L. Gibson, Sharon McNamara, Bonnie W. Ramsey, Richard B. Moss, Moira L. Aitken, Julia Emerson, David Waltz, Brian O’Sullivan and Robert Gerstle and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and CHEST Journal.

In The Last Decade

Mark Dovey

13 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Dovey United States 11 644 184 167 145 98 13 874
Hans‐Georg Posselt Germany 14 463 0.7× 102 0.6× 30 0.2× 141 1.0× 80 0.8× 38 808
Tim Lee United Kingdom 6 595 0.9× 149 0.8× 43 0.3× 140 1.0× 51 0.5× 7 683
A Penketh United Kingdom 15 636 1.0× 107 0.6× 31 0.2× 230 1.6× 70 0.7× 23 971
T. Pressler Denmark 13 406 0.6× 179 1.0× 27 0.2× 76 0.5× 28 0.3× 28 614
A. Sewall United States 4 548 0.9× 90 0.5× 21 0.1× 103 0.7× 28 0.3× 5 643
Héctor Escobar Spain 12 272 0.4× 92 0.5× 21 0.1× 200 1.4× 36 0.4× 33 578
J.L. Whitehouse United Kingdom 13 298 0.5× 193 1.0× 90 0.5× 50 0.3× 22 0.2× 39 498
A Equi United Kingdom 6 421 0.7× 92 0.5× 10 0.1× 176 1.2× 92 0.9× 7 541
Anne Prévötat France 11 626 1.0× 198 1.1× 13 0.1× 154 1.1× 71 0.7× 25 853
Lisa A. Moulton United States 7 387 0.6× 352 1.9× 21 0.1× 82 0.6× 32 0.3× 8 626

Countries citing papers authored by Mark Dovey

Since Specialization
Citations

This map shows the geographic impact of Mark Dovey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dovey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dovey more than expected).

Fields of papers citing papers by Mark Dovey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dovey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dovey. The network helps show where Mark Dovey may publish in the future.

Co-authorship network of co-authors of Mark Dovey

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dovey. A scholar is included among the top collaborators of Mark Dovey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dovey. Mark Dovey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sheares, Beverley J., Robert B. Mellins, Emily DiMango, et al.. (2015). Do Patients of Subspecialist Physicians Benefit from Written Asthma Action Plans?. American Journal of Respiratory and Critical Care Medicine. 191(12). 1374–1383. 39 indexed citations
2.
Rice, Jessica L., et al.. (2015). LEAP: A randomized–controlled trial of a lay-educator inpatient asthma education program. Patient Education and Counseling. 98(12). 1585–1591. 20 indexed citations
3.
Dovey, Mark, Moira L. Aitken, Julia Emerson, et al.. (2007). Oral Corticosteroid Therapy in Cystic Fibrosis Patients Hospitalized for Pulmonary Exacerbation. CHEST Journal. 132(4). 1212–1218. 42 indexed citations
4.
Comeau, Anne Marie, Richard B. Parad, Robert Gerstle, et al.. (2005). Communications Systems and their Models: Massachusetts Parent Compliance with Recommended Specialty Care after Positive Cystic Fibrosis Newborn Screening Result. The Journal of Pediatrics. 147(3). S98–S100. 13 indexed citations
5.
Comeau, Anne Marie, Richard B. Parad, Robert Gerstle, et al.. (2005). Challenges in Implementing a Successful Newborn Cystic Fibrosis Screening Program. The Journal of Pediatrics. 147(3). S89–S93. 7 indexed citations
6.
Parad, Richard B., Anne Marie Comeau, Henry L. Dorkin, et al.. (2005). Sweat Testing Infants Detected by Cystic Fibrosis Newborn Screening. The Journal of Pediatrics. 147(3). S69–S72. 42 indexed citations
7.
Kalish, Leslie A., David A. Waltz, Mark Dovey, et al.. (2005). Impact of Burkholderia dolosa on Lung Function and Survival in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 173(4). 421–425. 100 indexed citations
8.
9.
Gibson, Ronald L., Julia Emerson, Sharon McNamara, et al.. (2003). Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 167(6). 841–849. 243 indexed citations
10.
Noone, Peadar G., N. Hamblett, Frank J. Accurso, et al.. (2001). Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study. Pediatric Pulmonology. 32(2). 122–128. 31 indexed citations
11.
Aitken, Moira L., Richard B. Moss, David A. Waltz, et al.. (2001). A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease. Human Gene Therapy. 12(15). 1907–1916. 189 indexed citations
12.
Noone, Peadar G., N. Hamblett, Frank J. Accurso, et al.. (2001). Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study. Pediatric Pulmonology. 32(2). 122–128. 1 indexed citations
13.
Dovey, Mark, et al.. (1989). Ultrastructural morphology of the lung in cystic fibrosis.. PubMed. 21(3). 521–34. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans‐Georg Posselt Breakdown of academic impact, for papers by Tim Lee Breakdown of academic impact, for papers by A Penketh Breakdown of academic impact, for papers by T. Pressler Breakdown of academic impact, for papers by A. Sewall Breakdown of academic impact, for papers by Héctor Escobar Breakdown of academic impact, for papers by J.L. Whitehouse Breakdown of academic impact, for papers by A Equi Breakdown of academic impact, for papers by Anne Prévötat Breakdown of academic impact, for papers by Lisa A. Moulton
Rankless by CCL
2026